The Clinical Significance of O(6)-Methylguanine-DNA Methyltransferase Promoter Methylation Status in Adult Patients With Glioblastoma: A Meta-analysis

BACKGROUND AND OBJECTIVE: Promoter status of O(6)-methylguanine-DNA methyltransferase (MGMT) has been widely established as a clinically relevant factor in glioblastoma (GBM) patients. However, in addition to varied therapy schedule, the prognosis of GBM patients is also affected by variations of ag...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Yu-Hang, Wang, Ze-Fen, Cao, Chang-Jun, Weng, Hong, Xu, Cheng-Shi, Li, Kai, Li, Jie-Li, Lan, Jing, Zeng, Xian-Tao, Li, Zhi-Qiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Neuroscience
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5873285/
https://www.ncbi.nlm.nih.gov/pubmed/29619003
http://dx.doi.org/10.3389/fneur.2018.00127

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5873285/
https://www.ncbi.nlm.nih.gov/pubmed/29619003
http://dx.doi.org/10.3389/fneur.2018.00127

Ejemplares similares